Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James M. Ahlers currently holds 51,000 shares of Cue Biopharma, Inc. (CUE), valued at approximately $0. This represents their equity stake as Chief Financial Officer.
Based on SEC Form 4 filings, James M. Ahlers has been a net neutral trader of CUE stock. They have purchased $0 and sold $0 worth of shares.
James M. Ahlers's most recent insider trade was on Jul 30, 2026, when they sold 51,000 shares at $0.00 per share.
James M. Ahlers serves as Chief Financial Officer at Cue Biopharma, Inc. (CUE). They have executed 2 insider transactions totaling $0 over their tenure at the company.
James M. Ahlers holds the position of Chief Financial Officer at Cue Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
James M. Ahlers has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by James M. Ahlers was on Jul 30, 2026, when they purchased $0 worth of CUE shares. This transaction involved 51,000 shares at N/A per share.
James M. Ahlers currently owns 51,000 shares of Cue Biopharma, Inc. (CUE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James M. Ahlers's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James M. Ahlers has 2 Form 4 filings on record as an insider at Cue Biopharma, Inc..
Set alerts for James M. Ahlers and 40,000+ other insiders.